A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects
NCT05332834
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
BIOLOGICAL:
SM17
OTHER:
Placebo
Sponsor
SinoMab BioScience Ltd